FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057888930> ?p ?o ?g. }

• W2057888930 endingPage "259" @default.
• W2057888930 startingPage "254" @default.
• W2057888930 abstract "Stem cell transplantation (SCT) is a useful treatment for hematological malignancies, but it is limited to younger patients because of its high treatment-related mortality. Fludarabine (Flu), a novel anticancer agent with potent immunosuppressive activity, used as a conditioning regimen (reduced intensity transplantation; RIST), can decrease treatment-related mortality, as recently reported. However, the best drug combination and the best timing for RIST remain unknown. We herein report the SCT outcomes of 36 patients undergoing Flu treatment at our institution since December 2002 and retrospectively analyze the results. RIST conditioning with Flu was well-tolerated. No severe toxicity related conditioning regimens was observed in our patients, even though there were 10 patients with a history of autologous (n=5) or allogeneic stem cell transplantation (n=5). Hematological engraftment was found in 33 patients. The median times for reconstitution of WBCs, RBCs, and platelets were 16 days, 27.5 days and 34 days, respectively. Stable complete donor chimerism after SCT was present in all patients with WBC engraftment, and no patients experienced late rejection. Thirty-two patients were evaluated for acute graft versus host disease (aGVHD). Nine patients had no aGVHD. The incidence of grade I/II and III/IV aGVHD was 78% and 22%, respectively. Skin lesions were the major sites of involvement. Gut involvement was present in 9 patients. All 4 patients with grade IV GVHD had stage four hepatic GVHD. Twenty-two patients were analyzed for chronic GVHD (cGVHD). Twelve patients had no cGVHD, 6 had limited type and 4 had extended type. The overall survival (OS), relapse rate (RR), and non-relapse mortality (NRM) in all patients over 7 years were found to be 41.7%, 20.1%, and 34.6%, respectively. Induction failures were present in 5 cases of AML and 1 case of NHL. Disease progression was the primary cause of death, which occurred in 12 of 21 patients. Six patients died of grade IV GVHD (n=2) or complicated fungal infection contracted during the GVHD treatment (n=4). One patient died of secondary MSD, which originated from donor hematopoietic cells. Two patients died of cerebral bleeding and cardiac rapture, respectively. We found that the patients' state on SCT was the most important factor in long-term survival. The OS of standard risk and high risk patients with hematological malignancies were 75% and 30.3%. We concluded that stem cell transplantation using a non-myeloablative conditioning regimen with Flu was a useful therapeutic approach for patients with hematological malignancies." @default.
• W2057888930 created "2016-06-24" @default.
• W2057888930 creator A5033007975 @default.
• W2057888930 creator A5035858921 @default.
• W2057888930 creator A5044961502 @default.
• W2057888930 creator A5056051352 @default.
• W2057888930 creator A5064206219 @default.
• W2057888930 creator A5089743694 @default.
• W2057888930 date "2010-01-01" @default.
• W2057888930 modified "2023-10-06" @default.
• W2057888930 title "Stem Cell Transplantation Using Non-myeloablative Conditioning Regimen with Fludarabine for Hematological Malignancies" @default.
• W2057888930 cites W1968223818 @default.
• W2057888930 cites W1984432386 @default.
• W2057888930 cites W1990247501 @default.
• W2057888930 cites W1990883298 @default.
• W2057888930 cites W2001085847 @default.
• W2057888930 cites W2029173845 @default.
• W2057888930 cites W2044507524 @default.
• W2057888930 cites W2060940696 @default.
• W2057888930 cites W2067114649 @default.
• W2057888930 cites W2115750869 @default.
• W2057888930 cites W24911164 @default.
• W2057888930 doi "https://doi.org/10.1272/jnms.77.254" @default.
• W2057888930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21060236" @default.
• W2057888930 hasPublicationYear "2010" @default.
• W2057888930 type Work @default.
• W2057888930 sameAs 2057888930 @default.
• W2057888930 citedByCount "2" @default.
• W2057888930 countsByYear W20578889302013 @default.
• W2057888930 countsByYear W20578889302015 @default.
• W2057888930 crossrefType "journal-article" @default.
• W2057888930 hasAuthorship W2057888930A5033007975 @default.
• W2057888930 hasAuthorship W2057888930A5035858921 @default.
• W2057888930 hasAuthorship W2057888930A5044961502 @default.
• W2057888930 hasAuthorship W2057888930A5056051352 @default.
• W2057888930 hasAuthorship W2057888930A5064206219 @default.
• W2057888930 hasAuthorship W2057888930A5089743694 @default.
• W2057888930 hasBestOaLocation W20578889301 @default.
• W2057888930 hasConcept C120665830 @default.
• W2057888930 hasConcept C121332964 @default.
• W2057888930 hasConcept C126322002 @default.
• W2057888930 hasConcept C141071460 @default.
• W2057888930 hasConcept C194409129 @default.
• W2057888930 hasConcept C2776694085 @default.
• W2057888930 hasConcept C2776755627 @default.
• W2057888930 hasConcept C2779263901 @default.
• W2057888930 hasConcept C2779972918 @default.
• W2057888930 hasConcept C2781413609 @default.
• W2057888930 hasConcept C2911091166 @default.
• W2057888930 hasConcept C61511704 @default.
• W2057888930 hasConcept C71924100 @default.
• W2057888930 hasConcept C90924648 @default.
• W2057888930 hasConceptScore W2057888930C120665830 @default.
• W2057888930 hasConceptScore W2057888930C121332964 @default.
• W2057888930 hasConceptScore W2057888930C126322002 @default.
• W2057888930 hasConceptScore W2057888930C141071460 @default.
• W2057888930 hasConceptScore W2057888930C194409129 @default.
• W2057888930 hasConceptScore W2057888930C2776694085 @default.
• W2057888930 hasConceptScore W2057888930C2776755627 @default.
• W2057888930 hasConceptScore W2057888930C2779263901 @default.
• W2057888930 hasConceptScore W2057888930C2779972918 @default.
• W2057888930 hasConceptScore W2057888930C2781413609 @default.
• W2057888930 hasConceptScore W2057888930C2911091166 @default.
• W2057888930 hasConceptScore W2057888930C61511704 @default.
• W2057888930 hasConceptScore W2057888930C71924100 @default.
• W2057888930 hasConceptScore W2057888930C90924648 @default.
• W2057888930 hasIssue "5" @default.
• W2057888930 hasLocation W20578889301 @default.
• W2057888930 hasLocation W20578889302 @default.
• W2057888930 hasOpenAccess W2057888930 @default.
• W2057888930 hasPrimaryLocation W20578889301 @default.
• W2057888930 hasRelatedWork W2023136491 @default.
• W2057888930 hasRelatedWork W2058090754 @default.
• W2057888930 hasRelatedWork W2081782066 @default.
• W2057888930 hasRelatedWork W2092132051 @default.
• W2057888930 hasRelatedWork W2348447494 @default.
• W2057888930 hasRelatedWork W2360634842 @default.
• W2057888930 hasRelatedWork W2556494698 @default.
• W2057888930 hasRelatedWork W2796156257 @default.
• W2057888930 hasRelatedWork W3174720739 @default.
• W2057888930 hasRelatedWork W3180209262 @default.
• W2057888930 hasVolume "77" @default.
• W2057888930 isParatext "false" @default.
• W2057888930 isRetracted "false" @default.
• W2057888930 magId "2057888930" @default.
• W2057888930 workType "article" @default.